Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI

• Status: Not yet recruiting
• Trial end date: 2021-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Effect of upstream treatment with high intensity statin on the outcome of ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Assiut University
• Treatments: Aspirin; Atorvastatin; Ticagrelor

Criteria

Inclusion Criteria:

• STEMI patients eligible for primary PCI presented to Assiut university heart hospital.

Exclusion Criteria:

• Previous (within 3 months) or current treatment with statins

• Patients with contraindications to statins.

• Patients with cardiogenic shock.

• Patients with acute STEMI not eligible for Primary.

• Patients with other factors affecting leucocytic count such as active infection or leukemia.

• Inability to provide informed consent